Breaking News
-
Breaking News | Promotions & Moves
SARmont
Dr. John Talley has been appointed chief scientific officer of SARmont, a provider of medicinal chemistry services.05.27.11
-
Breaking News | CRO News | Logistics
Pfizer Selects PAREXEL, ICON As Strategic Partners
Pfizer has selected PAREXEL International and ICON plc as preferred providers for clinical trial services.05.26.11
-
Breaking News | Industry News
Johnson & Johnson Highlights Growth Strategy
Johnson & Johnson will review growth strategies for its Pharmaceuticals business and address therapeutic area strategy, advancing key compounds in its pipeline, and leveraging global market strategies to grow market share and expand geographic presence.05.26.11
-
Breaking News | Collaborations & Alliances
PharmaNet, HMR in Renal PK Pact
PharmaNet Development Group’s subsidiary, PharmaNet Canada, Inc. and Maisonneuve-Rosemont Hospital (HMR) and its Research Center, have agreed to collaborate in the conduct of pharmacokinetic studies in patients with impaired renal function.05.26.11
-
Breaking News | Industry News
Labtec Opens GMP Facility in Germany
Labtec GmbH, a subsidiary of tesa SE, has opened its new GMP manufacturing facility for transdermal drug delivery systems (TDS) and oral dispersible films (ODF) employing its RapidFilm technology.05.26.11
-
Breaking News | Logistics | Promotions & Moves | Supply Chain
-
Breaking News | Collaborations & Alliances
-
Breaking News | Packaging & Tracking | Vials
SCHOTT Launches Packaging Site in Russia
Primary packaging site to provide ampoules and vials05.25.11
-
Breaking News | Collaborations & Alliances
-
Bio News | Breaking News | Process Development
-
Breaking News | Collaborations & Alliances
-
Breaking News | Industry News
Lilly Forms Critical Care Company
Eli Lilly and Co. has signed agreements with private investors Care Capital and NovaQuest Capital to establish BioCritica, Inc., a new, privately held biotechnology company.05.24.11
-
Breaking News | CRO News
ICON Central Labs Launches Cytometry Services
ICON has launched cytometry services from its Central Laboratories business unit to support the testing requirements and development phase of compounds.05.24.11
-
Breaking News | Collaborations & Alliances
Xcellerex, Gallus In Biomanufacturing Pact
Xcellerex, Inc. and Gallus BioPharmaceuticals, LLC have entered into a collaboration to provide Gallus with expanded cGMP biomanufacturing capacity using Xcellerex’s FlexFactory GMP manufacturing platform suite.05.24.11
-
Breaking News | Industry News | Process Development
Biologics Process Development Doubles Lab Size
Biologics Process Development Inc. (BPD), a wholly-owned subsidiary of Viropro, will double the size of its existing bioprocess and scale-up lab in Poway, CA.05.24.11
-
Breaking News | Promotions & Moves | Validation
-
Breaking News | Promotions & Moves | Regulatory Affairs
-
Breaking News | Industry News
Par To Acquire Edict
Par Pharmaceutical Companies will acquire Edict Pharmaceuticals, a generics company based in India, for as much as $37.6 million in cash and the repayment of certain additional debt.05.23.11
-
Breaking News | Industry News
Advion Opens Midwest Center of Excellence
Advion BioServices, a subsidiary of Advion BioSciences, Inc., has opened its new 22,000-sq.-ft. Drug Discovery and Metabolism bioanalytical lab in Indianapolis, IN.05.23.11
-
Breaking News | Industry News
Almac Opens North American Headquarters
The Almac Group opened its new North American Headquarters in Souderton, PA.05.23.11
